Copyright Reports & Markets. All rights reserved.

Global Genomics In Cancer Care Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Instruments
    • 1.4.3 Consumables
    • 1.4.4 Services
  • 1.5 Market by Application
    • 1.5.1 Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostics
    • 1.5.3 Personalized Medicine
    • 1.5.4 Drug Discovery
    • 1.5.5 Development
    • 1.5.6 Research
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Genomics In Cancer Care Market Perspective (2015-2026)
  • 2.2 Global Genomics In Cancer Care Growth Trends by Regions
    • 2.2.1 Genomics In Cancer Care Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Genomics In Cancer Care Historic Market Share by Regions (2015-2020)
    • 2.2.3 Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Genomics In Cancer Care Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Genomics In Cancer Care Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Genomics In Cancer Care Players by Market Size
    • 3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2015-2020)
    • 3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Genomics In Cancer Care Market Concentration Ratio
    • 3.2.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2019
  • 3.3 Genomics In Cancer Care Key Players Head office and Area Served
  • 3.4 Key Players Genomics In Cancer Care Product Solution and Service
  • 3.5 Date of Enter into Genomics In Cancer Care Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Genomics In Cancer Care Historic Market Size by Type (2015-2020)
  • 4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Genomics In Cancer Care Market Size by Application (2015-2020)
  • 5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Genomics In Cancer Care Market Size (2015-2020)
  • 6.2 Genomics In Cancer Care Key Players in North America (2019-2020)
  • 6.3 North America Genomics In Cancer Care Market Size by Type (2015-2020)
  • 6.4 North America Genomics In Cancer Care Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Genomics In Cancer Care Market Size (2015-2020)
  • 7.2 Genomics In Cancer Care Key Players in Europe (2019-2020)
  • 7.3 Europe Genomics In Cancer Care Market Size by Type (2015-2020)
  • 7.4 Europe Genomics In Cancer Care Market Size by Application (2015-2020)

8 China

  • 8.1 China Genomics In Cancer Care Market Size (2015-2020)
  • 8.2 Genomics In Cancer Care Key Players in China (2019-2020)
  • 8.3 China Genomics In Cancer Care Market Size by Type (2015-2020)
  • 8.4 China Genomics In Cancer Care Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Genomics In Cancer Care Market Size (2015-2020)
  • 9.2 Genomics In Cancer Care Key Players in Japan (2019-2020)
  • 9.3 Japan Genomics In Cancer Care Market Size by Type (2015-2020)
  • 9.4 Japan Genomics In Cancer Care Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Genomics In Cancer Care Market Size (2015-2020)
  • 10.2 Genomics In Cancer Care Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020)

11 India

  • 11.1 India Genomics In Cancer Care Market Size (2015-2020)
  • 11.2 Genomics In Cancer Care Key Players in India (2019-2020)
  • 11.3 India Genomics In Cancer Care Market Size by Type (2015-2020)
  • 11.4 India Genomics In Cancer Care Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Genomics In Cancer Care Market Size (2015-2020)
  • 12.2 Genomics In Cancer Care Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Genomics In Cancer Care Market Size by Type (2015-2020)
  • 12.4 Central & South America Genomics In Cancer Care Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Illumina
    • 13.1.1 Illumina Company Details
    • 13.1.2 Illumina Business Overview
    • 13.1.3 Illumina Genomics In Cancer Care Introduction
    • 13.1.4 Illumina Revenue in Genomics In Cancer Care Business (2015-2020))
    • 13.1.5 Illumina Recent Development
  • 13.2 Thermo Fisher scientific
    • 13.2.1 Thermo Fisher scientific Company Details
    • 13.2.2 Thermo Fisher scientific Business Overview
    • 13.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
    • 13.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.2.5 Thermo Fisher scientific Recent Development
  • 13.3 Agilent
    • 13.3.1 Agilent Company Details
    • 13.3.2 Agilent Business Overview
    • 13.3.3 Agilent Genomics In Cancer Care Introduction
    • 13.3.4 Agilent Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.3.5 Agilent Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview
    • 13.4.3 Roche Genomics In Cancer Care Introduction
    • 13.4.4 Roche Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Cancer Genetics
    • 13.5.1 Cancer Genetics Company Details
    • 13.5.2 Cancer Genetics Business Overview
    • 13.5.3 Cancer Genetics Genomics In Cancer Care Introduction
    • 13.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.5.5 Cancer Genetics Recent Development
  • 13.6 Beckman Coulter
    • 13.6.1 Beckman Coulter Company Details
    • 13.6.2 Beckman Coulter Business Overview
    • 13.6.3 Beckman Coulter Genomics In Cancer Care Introduction
    • 13.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.6.5 Beckman Coulter Recent Development
  • 13.7 Bio-Rad
    • 13.7.1 Bio-Rad Company Details
    • 13.7.2 Bio-Rad Business Overview
    • 13.7.3 Bio-Rad Genomics In Cancer Care Introduction
    • 13.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.7.5 Bio-Rad Recent Development
  • 13.8 Danaher
    • 13.8.1 Danaher Company Details
    • 13.8.2 Danaher Business Overview
    • 13.8.3 Danaher Genomics In Cancer Care Introduction
    • 13.8.4 Danaher Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.8.5 Danaher Recent Development
  • 13.9 Sigma Aldrich
    • 13.9.1 Sigma Aldrich Company Details
    • 13.9.2 Sigma Aldrich Business Overview
    • 13.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
    • 13.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.9.5 Sigma Aldrich Recent Development
  • 13.10 Pacific Biosciences
    • 13.10.1 Pacific Biosciences Company Details
    • 13.10.2 Pacific Biosciences Business Overview
    • 13.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
    • 13.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020)
    • 13.10.5 Pacific Biosciences Recent Development
  • 13.11 Quest Diagnostics
    • 10.11.1 Quest Diagnostics Company Details
    • 10.11.2 Quest Diagnostics Business Overview
    • 10.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
    • 10.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020)
    • 10.11.5 Quest Diagnostics Recent Development
  • 13.12 Luminex
    • 10.12.1 Luminex Company Details
    • 10.12.2 Luminex Business Overview
    • 10.12.3 Luminex Genomics In Cancer Care Introduction
    • 10.12.4 Luminex Revenue in Genomics In Cancer Care Business (2015-2020)
    • 10.12.5 Luminex Recent Development
  • 13.13 Oxford Gene Technology
    • 10.13.1 Oxford Gene Technology Company Details
    • 10.13.2 Oxford Gene Technology Business Overview
    • 10.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
    • 10.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020)
    • 10.13.5 Oxford Gene Technology Recent Development
  • 13.14 PerkinElmer
    • 10.14.1 PerkinElmer Company Details
    • 10.14.2 PerkinElmer Business Overview
    • 10.14.3 PerkinElmer Genomics In Cancer Care Introduction
    • 10.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020)
    • 10.14.5 PerkinElmer Recent Development
  • 13.15 Qiagen
    • 10.15.1 Qiagen Company Details
    • 10.15.2 Qiagen Business Overview
    • 10.15.3 Qiagen Genomics In Cancer Care Introduction
    • 10.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2015-2020)
    • 10.15.5 Qiagen Recent Development
  • 13.16 GE Healthcare
    • 10.16.1 GE Healthcare Company Details
    • 10.16.2 GE Healthcare Business Overview
    • 10.16.3 GE Healthcare Genomics In Cancer Care Introduction
    • 10.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020)
    • 10.16.5 GE Healthcare Recent Development
  • 13.17 Thermo Fisher scientific
    • 10.17.1 Thermo Fisher scientific Company Details
    • 10.17.2 Thermo Fisher scientific Business Overview
    • 10.17.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
    • 10.17.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
    • 10.17.5 Thermo Fisher scientific Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Genomics In Cancer Care market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Genomics In Cancer Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Illumina
    Thermo Fisher scientific
    Agilent
    Roche
    Cancer Genetics
    Beckman Coulter
    Bio-Rad
    Danaher
    Sigma Aldrich
    Pacific Biosciences
    Quest Diagnostics
    Luminex
    Oxford Gene Technology
    PerkinElmer
    Qiagen
    GE Healthcare
    Thermo Fisher scientific

    Market segment by Type, the product can be split into
    Instruments
    Consumables
    Services
    Market segment by Application, split into
    Diagnostics
    Personalized Medicine
    Drug Discovery
    Development
    Research

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now